IL130009A0 - Post-mitotic neurons containing adenovirus vectors that modulate apoptosis and growth - Google Patents

Post-mitotic neurons containing adenovirus vectors that modulate apoptosis and growth

Info

Publication number
IL130009A0
IL130009A0 IL13000997A IL13000997A IL130009A0 IL 130009 A0 IL130009 A0 IL 130009A0 IL 13000997 A IL13000997 A IL 13000997A IL 13000997 A IL13000997 A IL 13000997A IL 130009 A0 IL130009 A0 IL 130009A0
Authority
IL
Israel
Prior art keywords
growth
post
adenovirus vectors
modulate apoptosis
containing adenovirus
Prior art date
Application number
IL13000997A
Other languages
English (en)
Original Assignee
Univ Mcgill
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mcgill filed Critical Univ Mcgill
Publication of IL130009A0 publication Critical patent/IL130009A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL13000997A 1996-11-18 1997-11-18 Post-mitotic neurons containing adenovirus vectors that modulate apoptosis and growth IL130009A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3105796P 1996-11-18 1996-11-18
PCT/IB1997/001619 WO1998022608A2 (fr) 1996-11-18 1997-11-18 Neurones post-mitotiques contenant des vecteurs a base d'adenovirus qui modulent l'apoptose et la croissance

Publications (1)

Publication Number Publication Date
IL130009A0 true IL130009A0 (en) 2000-02-29

Family

ID=21857441

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13000997A IL130009A0 (en) 1996-11-18 1997-11-18 Post-mitotic neurons containing adenovirus vectors that modulate apoptosis and growth

Country Status (7)

Country Link
US (1) US6060247A (fr)
EP (1) EP0943004A2 (fr)
JP (1) JP2001505766A (fr)
AU (1) AU742696B2 (fr)
CA (1) CA2272578A1 (fr)
IL (1) IL130009A0 (fr)
WO (1) WO1998022608A2 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6551618B2 (en) * 1994-03-15 2003-04-22 University Of Birmingham Compositions and methods for delivery of agents for neuronal regeneration and survival
US20020009747A1 (en) * 1997-08-25 2002-01-24 Freda Diane Miller Methods and reagents for identifying modulators of neuronal apoptosis
EP1008242B1 (fr) * 1997-08-25 2003-11-05 McGILL UNIVERSITY Utilisation de shp-1 et shp-2 pour deceler des composes impliques dans la survie neuronale
US6811992B1 (en) * 1998-05-14 2004-11-02 Ya Fang Liu Method for identifying MLK inhibitors for the treatment of neurological conditions
EP1173254A2 (fr) * 1999-04-27 2002-01-23 Smithkline Beecham Plc Nouveau traitement de conditions neurotraumatiques avec un inhibiteur de raf
AU5599500A (en) * 1999-06-07 2000-12-28 J. David Gladstone Institutes, The Methods and compositions for preventing p53 mediated apoptosis
IL147793A0 (en) * 1999-08-05 2002-08-14 Cellomics Inc Optical system analysis of cells
EP1107003A1 (fr) * 1999-12-09 2001-06-13 Trophos Méthodes pour criblage des composés avec activité sur les neurones
WO2002007776A1 (fr) * 2000-07-26 2002-01-31 University Of Maryland Baltimore Activité anti-apoptotique du domaine protéine-kinase de la grande sous-unité de la réductase du ribonucléotide de type 2 d'herpès simplex (icp10pjk)
US20040049024A1 (en) * 2001-12-07 2004-03-11 Geoff Clark Compositions and methods related to the minn1 tumor suppressor gene and protein
US20040001808A1 (en) * 2002-06-07 2004-01-01 Kenneth Haglid Compositions and methods for the use of Bcl-2 transfected neurons
CA2899360A1 (fr) 2002-08-21 2004-04-08 Revivicor, Inc. Porcins ne presentant aucune expression de l'alpha 1,3-galactosyltransferase fonctionnelle
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
WO2005039600A2 (fr) * 2003-10-21 2005-05-06 Aga Ab Emploi du xenon pour contrer la mort programmee des cellules
JP2008507294A (ja) 2004-07-26 2008-03-13 ダウ グローバル テクノロジーズ インコーポレイティド 菌株遺伝子操作による改善されたタンパク質発現のための方法
AU2006292827B2 (en) 2005-08-09 2013-02-14 Revivicor, Inc. Transgenic ungulates expressing CTLA4-IG and uses thereof
AU2008229648A1 (en) * 2007-03-20 2008-09-25 The Walter And Eliza Hall Institute Of Medical Research Method of screening
AU2008245696B2 (en) 2007-04-27 2013-11-07 Pelican Technology Holdings, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992013091A1 (fr) * 1991-01-18 1992-08-06 Oncogene Science, Inc. Procede de modulation par transcription de l'expression genique d'oncogenes et de genes supprimant les tumeurs
US5747469A (en) * 1991-03-06 1998-05-05 Board Of Regents, The University Of Texas System Methods and compositions comprising DNA damaging agents and p53
US6410010B1 (en) * 1992-10-13 2002-06-25 Board Of Regents, The University Of Texas System Recombinant P53 adenovirus compositions
AU682854B2 (en) * 1993-02-16 1997-10-23 Onyx Pharmaceuticals Cytopathic viruses for therapy and prophylaxis of neoplasia
WO1995005738A1 (fr) * 1993-08-20 1995-03-02 Massachusetts Institute Of Technology Agents anticancereux et apoptose
DE69434594T2 (de) * 1993-10-25 2006-09-21 Canji, Inc., San Diego Rekombinante adenoviren-vektor und verfahren zur verwendung
WO1995013392A1 (fr) * 1993-11-09 1995-05-18 Medical College Of Ohio Lignees cellulaires stables aptes a exprimer le gene de replication du virus adeno-associe
WO1995027494A1 (fr) * 1994-04-11 1995-10-19 Sloan-Kettering Institute For Cancer Research VECTEURS DE VIRUS HERPES DEFECTIFS ET DE VIRUS ADENO-ASSOCIES DEFECTIFS COMPORTANT p53 ET DESTINES AU TRAITEMENT DU CANCER
US5723333A (en) * 1995-02-10 1998-03-03 Regents Of The University Of California Human pancreatic cell lines: developments and uses

Also Published As

Publication number Publication date
US6060247A (en) 2000-05-09
AU5406498A (en) 1998-06-10
CA2272578A1 (fr) 1998-05-28
WO1998022608A2 (fr) 1998-05-28
JP2001505766A (ja) 2001-05-08
AU742696B2 (en) 2002-01-10
EP0943004A2 (fr) 1999-09-22
WO1998022608A3 (fr) 1998-09-03

Similar Documents

Publication Publication Date Title
IL130009A0 (en) Post-mitotic neurons containing adenovirus vectors that modulate apoptosis and growth
GB9620392D0 (en) Spatial light modulator and directional display
EP0925175A4 (fr) Formulations contenant de la maleimide et utilisations de ces dernieres
GB9620390D0 (en) Substances and their uses
IL121716A0 (en) Polarization-insensitive electro-optic modulator
HUP9903444A3 (en) Modified/chimeric superantigens and their use
ZA972507B (en) Benzothiophenes formulations containing same and methods
GB9625899D0 (en) Substances and their uses
ZA9710419B (en) Compositions and methods for regulating apoptosis
ZA9510854B (en) Liquid distribution and retention medium
GB9601618D0 (en) Spatial light modulator and directional display
GB2313592B (en) Improvements in cable drums
ZA971412B (en) Benzothiophenes formulations containing same and methods
DE69633521D1 (en) Photothermographic recording material
IL125863A (en) Benzothiophenes and formulations containing same
IL126320A0 (en) Benzothiophenes formulations containing same and methods
EP0917669A4 (fr) Toner liquide et systeme d'impression d'images
GB2313505B (en) Digital and analog modulator
HUP9900068A3 (en) Fuse-switch and/or fuse-disconnector
GB9618123D0 (en) Double-sided electro-optic modulator array
AU3753099A (en) Novel genes and methods that modulate apoptosis
HK1003148A2 (en) Containers for jelly and containers containing jelly
GB2320149B (en) Modulators
IL115354A0 (en) Controllable encryption and decryption
HK1019227A1 (en) Compounds containing alkoxysilane groups and hydanton groups